CUFinder

Timothy Cloughesy

About Timothy Cloughesy

Timothy Cloughesy, With an exceptional h-index of 132 and a recent h-index of 78 (since 2020), a distinguished researcher at University of California, Los Angeles, specializes in the field of Brain Cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

A Randomized, Double-blind, Phase 3 Study of Vorasidenib Versus Placebo in Patients with Mutant IDH1/2 Diffuse Glioma (INDIGO): Analysis of Health-related Quality of Life …

D-2-HG Inhibits IDH1mut Glioma Growth via FTO Inhibition and Resultant m6A Hypermethylation

ACTION: A randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma

Compositions and methods for treating cancer

Selective DRD2 Antagonist and ClpP Agonist ONC201 in a Recurrent Non-midline H3 K27M-mutant Glioma Cohort

ONC201 (Dordaviprone) in Recurrent H3 K27M–Mutant Diffuse Midline Glioma

Quantification of T2-FLAIR Mismatch in Nonenhancing Diffuse Gliomas Using Digital Subtraction

Author Correction: Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial

Timothy Cloughesy Information

University

Position

___

Citations(all)

67469

Citations(since 2020)

28180

Cited By

50252

hIndex(all)

132

hIndex(since 2020)

78

i10Index(all)

452

i10Index(since 2020)

355

Email

University Profile Page

Google Scholar

Timothy Cloughesy Skills & Research Interests

Brain Cancer

Top articles of Timothy Cloughesy

A Randomized, Double-blind, Phase 3 Study of Vorasidenib Versus Placebo in Patients with Mutant IDH1/2 Diffuse Glioma (INDIGO): Analysis of Health-related Quality of Life …

2024/4/14

Mehdi Touat
Mehdi Touat

H-Index: 19

Warren Mason
Warren Mason

H-Index: 46

Matthias Holdhoff
Matthias Holdhoff

H-Index: 24

Yoshiki Arakawa
Yoshiki Arakawa

H-Index: 23

Wolfgang Wick
Wolfgang Wick

H-Index: 92

James Perry
James Perry

H-Index: 30

Dan Zhao
Dan Zhao

H-Index: 14

Islam Hassan
Islam Hassan

H-Index: 11

Timothy Cloughesy
Timothy Cloughesy

H-Index: 78

D-2-HG Inhibits IDH1mut Glioma Growth via FTO Inhibition and Resultant m6A Hypermethylation

Cancer Research Communications

2024/3/22

Matteo Pellegrini
Matteo Pellegrini

H-Index: 68

ACTION: A randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma

2024/3/6

Sabine Mueller
Sabine Mueller

H-Index: 16

Timothy Cloughesy
Timothy Cloughesy

H-Index: 78

Compositions and methods for treating cancer

2014/6/12

Selective DRD2 Antagonist and ClpP Agonist ONC201 in a Recurrent Non-midline H3 K27M-mutant Glioma Cohort

2024/2/22

ONC201 (Dordaviprone) in Recurrent H3 K27M–Mutant Diffuse Midline Glioma

Journal of Clinical Oncology

2024/2/9

Timothy Cloughesy
Timothy Cloughesy

H-Index: 78

Lynne Taylor
Lynne Taylor

H-Index: 3

Quantification of T2-FLAIR Mismatch in Nonenhancing Diffuse Gliomas Using Digital Subtraction

American Journal of Neuroradiology

2024/2/1

Jingwen Yao
Jingwen Yao

H-Index: 8

Donatello Telesca
Donatello Telesca

H-Index: 21

Noriko Salamon
Noriko Salamon

H-Index: 35

Author Correction: Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial

Nature medicine

2024

Min Lu
Min Lu

H-Index: 3

Islam Hassan
Islam Hassan

H-Index: 11

dCas9/CRISPR-based methylation of O-6-methylguanine-DNA methyltransferase enhances chemosensitivity to temozolomide in malignant glioma

Journal of Neuro-oncology

2024/1

pH-Weighted amine chemical exchange saturation transfer echo planar imaging visualizes infiltrating glioblastoma cells

Neuro-oncology

2024/1/1

Jingwen Yao
Jingwen Yao

H-Index: 8

Alvaro Alvarado
Alvaro Alvarado

H-Index: 16

Fausto Rodriguez
Fausto Rodriguez

H-Index: 42

Richard Everson
Richard Everson

H-Index: 25

Noriko Salamon
Noriko Salamon

H-Index: 35

P11. 29. B UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.)

2023/9/8

E Lee
E Lee

H-Index: 8

DNAR-05. EXCEPTIONAL RESPONDERS TO BASE EXCISION REPAIR (BER) INHIBITION FOR RECURRENT GLIOBLASTOMA DISPLAY ENRICHMENT FOR DNA DAMAGE RESPONSE PATHWAYS: RNA SEQUENCING ANALYSIS …

Neuro-Oncology

2023/11/1

Matthias Holdhoff
Matthias Holdhoff

H-Index: 24

Timothy Cloughesy
Timothy Cloughesy

H-Index: 78

Lisa Rogers
Lisa Rogers

H-Index: 2

Abstract CT060: ACTION: A randomized phase 3 study of dordaviprone (ONC201) in patients with newly diagnosed H3 K27M-mutant diffuse glioma

Cancer Research

2023/4/14

Sabine Mueller
Sabine Mueller

H-Index: 16

Louis B Nabors
Louis B Nabors

H-Index: 40

P15. 04. A BIOLOGICAL CORRELATES OF LEAKAGE EFFECT METRICS COMPUTED FROM DYNAMIC SAGE-EPI MRI IN ENHANCING AND NON-ENHANCING HUMAN GLIOMAS

Neuro-Oncology

2023/9/1

J Yao
J Yao

H-Index: 6

Abstract CT062: GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma

Cancer Research

2023/4/14

Webster Cavenee
Webster Cavenee

H-Index: 59

Gary Gordon
Gary Gordon

H-Index: 8

Mustafa Khasraw
Mustafa Khasraw

H-Index: 24

Wenbin Li
Wenbin Li

H-Index: 6

Michael Lim
Michael Lim

H-Index: 3

James Perry
James Perry

H-Index: 30

Timothy Cloughesy
Timothy Cloughesy

H-Index: 78

Immune checkpoint blockade induces distinct alterations in the microenvironments of primary and metastatic brain tumors

Journal of Clinical Investigation

2023/9/1

Lu Sun
Lu Sun

H-Index: 1

Alexander Lee
Alexander Lee

H-Index: 9

Eileen Shiuan
Eileen Shiuan

H-Index: 5

Jiyoon Kim
Jiyoon Kim

H-Index: 2

Lizhong Ding
Lizhong Ding

H-Index: 5

David Nathanson
David Nathanson

H-Index: 21

Gang Li
Gang Li

H-Index: 7

Won Kim
Won Kim

H-Index: 30

CTNI-85. GBM AGILE PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GBM: RESULTS OF FIRST EXPERIMENTAL ARM, REGORAFENIB

Neuro-Oncology

2023/11/1

Webster Cavenee
Webster Cavenee

H-Index: 59

Gary Gordon
Gary Gordon

H-Index: 8

Mustafa Khasraw
Mustafa Khasraw

H-Index: 24

Michael Lim
Michael Lim

H-Index: 3

James Perry
James Perry

H-Index: 30

Andrew Brenner
Andrew Brenner

H-Index: 5

David Schiff
David Schiff

H-Index: 11

Timothy Cloughesy
Timothy Cloughesy

H-Index: 78

Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial

Nature medicine

2023/3

Min Lu
Min Lu

H-Index: 3

Islam Hassan
Islam Hassan

H-Index: 11

The Future Glioblastoma Clinical Trials Landscape: Early Phase 0, Window of Opportunity, and Adaptive Phase I–III Studies

2023/9

Weng Kee Wong
Weng Kee Wong

H-Index: 24

Targeting the intrinsic apoptotic machinery in glioblastoma

2023/2/9

See List of Professors in Timothy Cloughesy University(University of California, Los Angeles)

Co-Authors

academic-engine

Useful Links

List of top 50 universities
List of top 100 universities
List of top 500 universities
Find Professors Email
Find Universities Email
CUFinder Academic Engine